由于收益超过预期,内部人购买股份,投资人增加了Organon & Co.的股权。 Investors boost stakes in Organon & Co., as earnings exceed expectations and insiders buy shares.

伊利诺伊市政退休基金和Oppenheimer & Co.公司大幅增加了在Organ & Co.的股份,后者分别增长48.5%和67.8%。 The Illinois Municipal Retirement Fund and Oppenheimer & Co. Inc. have significantly increased their holdings in Organon & Co., with the latter seeing a 48.5% and 67.8% rise respectively. 据Organ报告,每股收入为1.02美元,超过预期,内部人士通过购买股票表现出信心。 Organon reported earnings per share of $1.02, exceeding expectations, and insiders have shown confidence by purchasing shares. 该公司的市场上限为25.7亿美元,分析家预测该年的每股收入为3.68美元,评级为“Moderate Buy”。 The company has a market cap of $2.57 billion and analysts predict 3.68 earnings per share for the year, with a "Moderate Buy" rating.